Page last updated: 2024-08-21

medroxyprogesterone and Bipolar Disorder

medroxyprogesterone has been researched along with Bipolar Disorder in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (66.67)29.6817
2010's1 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Berk, M; Davis, SR; de Castella, A; Fitzgerald, P; Gavrilidis, E; Gurvich, C; Kulkarni, J; Mu, L; Scarr, E; Van Rheenen, TE; Wang, W; Worsley, R1
Anderson, R; Davis, SR; de Castella, A; Fitzgerald, P; Garland, KA; Headey, B; Kulkarni, J; Scaffidi, A1
Chan, CH; Huang, MC; Wang, YB1

Trials

2 trial(s) available for medroxyprogesterone and Bipolar Disorder

ArticleYear
A four week randomised control trial of adjunctive medroxyprogesterone and tamoxifen in women with mania.
    Psychoneuroendocrinology, 2014, Volume: 43

    Topics: Adult; Bipolar Disorder; Double-Blind Method; Estrogen Antagonists; Female; Gonadal Steroid Hormones; Humans; Medroxyprogesterone; Middle Aged; Protein Kinase C; Selective Estrogen Receptor Modulators; Tamoxifen; Treatment Outcome

2014
A pilot study of hormone modulation as a new treatment for mania in women with bipolar affective disorder.
    Psychoneuroendocrinology, 2006, Volume: 31, Issue:4

    Topics: Acute Disease; Adult; Analysis of Variance; Antimanic Agents; Bipolar Disorder; Double-Blind Method; Estradiol; Estrogen Antagonists; Female; Humans; Medroxyprogesterone; Middle Aged; Pilot Projects; Progesterone Congeners; Psychiatric Status Rating Scales; Statistics, Nonparametric; Tamoxifen; Treatment Outcome

2006

Other Studies

1 other study(ies) available for medroxyprogesterone and Bipolar Disorder

ArticleYear
Estrogen-progesterone combination for treatment-refractory post-partum mania.
    Psychiatry and clinical neurosciences, 2008, Volume: 62, Issue:1

    Topics: Adult; Antimanic Agents; Bipolar Disorder; Drug Resistance; Drug Therapy, Combination; Estrogens, Conjugated (USP); Female; Hormone Replacement Therapy; Humans; Medroxyprogesterone; Puerperal Disorders

2008